An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis
J Eur Acad Dermatol Venereol
.
2024 May;38(5):e424-e427.
doi: 10.1111/jdv.19652.
Epub 2023 Dec 10.
Authors
K Eyerich
1
2
,
J Krueger
3
,
M Stahle
1
,
K Schakel
4
,
C Conrad
5
,
A Armstrong
6
,
R Gniadecki
7
,
L Puig
8
,
T Scoble
9
,
N Williams
9
Affiliations
1
Karolinska Institute, Solna, Sweden.
2
University of Freiburg, Breisgau, Germany.
3
The Rockefeller University Hospital, New York, New York, USA.
4
Department of Dermatology, and Interdisciplinary Center for Inflammatory Diseases, Heidelberg University Hospital, Heidelberg, Germany.
5
Lausanne University Hospital, Lausanne, Switzerland.
6
University of Southern California, Los Angeles, California, USA.
7
University of Alberta, Edmonton, Alberta, Canada.
8
Autonomous University of Barcelona, Bellaterra, Spain.
9
Triducive Partners Limited, Royal Tunbridge Wells, UK.
PMID:
38071690
DOI:
10.1111/jdv.19652
No abstract available
Publication types
Letter
MeSH terms
Consensus*
Delphi Technique*
Humans
Psoriasis* / diagnosis
Severity of Illness Index
Grants and funding
Janssen Pharmaceuticals